Stent :: Medtronic to sell heart device in Europe

Medical device maker Medtronic Inc. said it received approval from European health regulators to sell a heart device that keeps arteries open.

Medtronic said it will immediately roll out in Europe, the Middle East and Asia — more than 40 countries in all — its Endeavor drug-eluting stent, a tiny, wire mesh tube coated with medicine that props open arteries during angioplasty procedures.

The medicine, which is licensed from Abbott Laboratories Inc., keeps the treated coronary arteries from reclogging, a common complication when traditional bare metal stents are used.

The worldwide market for drug-eluting stents is $5.5 billion and growing rapidly. Johnson & Johnson and Boston Scientific Corp. dominate the worldwide market for these devices, which have driven profits at both companies during the past year.


Do NOT follow this link or you will be banned from the site!